Literature DB >> 26242886

Association of Body Mass Index (BMI) with Patterns of Fundoplication Failure: Insights Gained.

Shunsuke Akimoto1, Kalyana C Nandipati1, Harit Kapoor1, Se Ryung Yamamoto1, Pradeep K Pallati1, Sumeet K Mittal2.   

Abstract

BACKGROUND: Obesity has been implicated as an important risk factor for fundoplication failure. However, the mechanism of fundoplication in obese patients is not fully understood. Our objective is to evaluate the patterns of failure in relation to the body mass index (BMI) undergoing re-operative intervention after failed fundoplication.
METHODS: After Institutional Review Board approval, the patients who underwent re-operative intervention for failed fundoplication between November 2008 and December 2013 were identified. Patients were classified into three groups: non-obese, obese, and morbidly obese (<30, 30-35, >35 BMI, respectively). Pre-operative assessment and operative procedure performed were compared between the groups.
RESULTS: One hundred twenty-four patients satisfied study criteria. Non-obese patients (53.2 %) had significantly more dysphagia as an indication for re-operative procedure (obese 31.6 %, p < 0.05; morbidly 16.7 %, p < 0.05). Obese and morbidly obese patients had significantly higher incidence of recurrent hiatal hernia than non-obese patients (88.7 vs. 65.6 %, p < 0.05). Morbidly obese patients had significantly higher incidence of disrupted fundoplication than non-obese patients (41.7 vs. 19.4 %, p < 0.05).
CONCLUSION: Similar anatomical failure patterns of state of fundoplication and recurrent hiatal hernia were noted between obese patients and morbidly obese patients and were distinct from non-obese patients.

Entities:  

Keywords:  Anti-reflux surgery; Failed fundoplication; Obesity; Redo fundoplication; Roux-en-Y

Mesh:

Year:  2015        PMID: 26242886     DOI: 10.1007/s11605-015-2907-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  18 in total

1.  Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass.

Authors:  Todd A Kellogg; Raphael Andrade; Michael Maddaus; Bridget Slusarek; Henry Buchwald; Sayeed Ikramuddin
Journal:  Surg Obes Relat Dis       Date:  2006-11-20       Impact factor: 4.734

2.  Clinical results of laparoscopic fundoplication at ten years after surgery.

Authors:  B Dallemagne; J Weerts; S Markiewicz; J-M Dewandre; C Wahlen; B Monami; C Jehaes
Journal:  Surg Endosc       Date:  2005-12-07       Impact factor: 4.584

3.  Elevated body mass disrupts the barrier to gastroesophageal reflux; discussion 1018-9.

Authors:  S A Wajed; C G Streets; C G Bremner; T R DeMeester
Journal:  Arch Surg       Date:  2001-09

Review 4.  Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis.

Authors:  Douglas A Corley; Ai Kubo
Journal:  Am J Gastroenterol       Date:  2006-09-04       Impact factor: 10.864

5.  Obesity increases oesophageal acid exposure.

Authors:  Hashem B El-Serag; Gulchin A Ergun; John Pandolfino; Stephanie Fitzgerald; Thomas Tran; Jennifer R Kramer
Journal:  Gut       Date:  2006-11-24       Impact factor: 23.059

Review 6.  A comprehensive review of laparoscopic redo fundoplication.

Authors:  Darren B van Beek; Edward D Auyang; Nathaniel J Soper
Journal:  Surg Endosc       Date:  2010-07-27       Impact factor: 4.584

7.  The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: a prospective study based on the Montreal Consensus.

Authors:  Carlos A S Madalosso; Richard R Gurski; Sidia M Callegari-Jacques; Daniel Navarini; Victor Thiesen; Fernando Fornari
Journal:  Ann Surg       Date:  2010-02       Impact factor: 12.969

8.  Complications and frequency of redo antireflux surgery in Denmark: a nationwide study, 1997-2005.

Authors:  Peter Funch-Jensen; Anette Bendixen; Maria Gerding Iversen; Henrik Kehlet
Journal:  Surg Endosc       Date:  2007-12-11       Impact factor: 4.584

9.  Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn.

Authors:  E J Patterson; D G Davis; Y Khajanchee; L L Swanström
Journal:  Surg Endosc       Date:  2003-07-21       Impact factor: 4.584

10.  Laparoscopic Roux-en-Y gastric bypass for recalcitrant gastroesophageal reflux disease in morbidly obese patients.

Authors:  Yaron Perry; Anita P Courcoulas; Hiran C Fernando; Percival O Buenaventura; James S McCaughan; James D Luketich
Journal:  JSLS       Date:  2004 Jan-Mar       Impact factor: 2.172

View more
  4 in total

1.  A retrospective multicenter analysis on redo-laparoscopic anti-reflux surgery: conservative or conversion fundoplication?

Authors:  Al-Warith Al Hashmi; Guillaume Pineton de Chambrun; Regis Souche; Martin Bertrand; Vito De Blasi; Eric Jacques; Santiago Azagra; Jean Michel Fabre; Frédéric Borie; Michel Prudhomme; Nicolas Nagot; Francis Navarro; Fabrizio Panaro
Journal:  Surg Endosc       Date:  2018-06-25       Impact factor: 4.584

2.  Roux-En-Y gastric bypass following failed fundoplication.

Authors:  Kathleen M Coakley; Steven A Groene; Paul D Colavita; Tanushree Prasad; Dimitris Stefanidis; Amy E Lincourt; Vedra A Augenstein; Keith Gersin; B Todd Heniford
Journal:  Surg Endosc       Date:  2018-01-23       Impact factor: 4.584

3.  Effects of the body mass index (BMI) on the surgical outcomes of laparoscopic fundoplication for gastro-esophageal reflux disease: a propensity score-matched analysis.

Authors:  Masato Hoshino; Nobuo Omura; Fumiaki Yano; Kazuto Tsuboi; Se Ryung Yamamoto; Shunsuke Akimoto; Takahiro Masuda; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2017-08-07       Impact factor: 2.549

4.  Patient-related risk factors associated with symptomatic recurrence requiring reoperation in laparoscopic hiatal hernia repair.

Authors:  Ryan Ellis; Grant Garwood; Anshu Khanna; Maamoun Harmouch; Charles C Miller; Farzaneh Banki
Journal:  Surg Open Sci       Date:  2019-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.